|
Volumn 2, Issue 6, 2006, Pages 314-315
|
Induction therapy for active lupus nephritis: Mycophenolate mofetil versus cyclophosphamide: Commentary
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATININE;
CYCLOPHOSPHAMIDE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
ADULT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CREATININE CLEARANCE;
DIARRHEA;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FATALITY;
DRUG SAFETY;
FEMALE;
HEMATURIA;
HUMAN;
INFECTION;
KIDNEY BIOPSY;
LUPUS ERYTHEMATOSUS NEPHRITIS;
MAJOR CLINICAL STUDY;
MALE;
NOTE;
PRIORITY JOURNAL;
PROTEIN URINE LEVEL;
PROTEINURIA;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
UNITED STATES;
URINE SEDIMENT;
ADMINISTRATION, ORAL;
ADULT;
CROSS-OVER STUDIES;
CYCLOPHOSPHAMIDE;
DRUG THERAPY, COMBINATION;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFUSIONS, INTRAVENOUS;
LUPUS NEPHRITIS;
MALE;
MYCOPHENOLIC ACID;
PREDNISONE;
REMISSION INDUCTION;
TREATMENT OUTCOME;
|
EID: 33745932919
PISSN: 17458323
EISSN: 17458331
Source Type: Journal
DOI: 10.1038/ncpneph0184 Document Type: Note |
Times cited : (9)
|
References (5)
|